New York City, NY -- (SBWIRE) -- 08/15/2013 -- StockMarketIntel.com issues a special report on the following stocks: SecureAlert Inc (OTCBB:SCRA), Exide Technologies (OTCMKTS:XIDEQ), Implant Sciences Corporation (OTCMKTS:IMSC), Titan Pharmaceuticals, Inc. (OTCBB:TTNP)
SecureAlert Inc (OTCBB:SCRA) gained2.5%, trading on 7,570 shares, to end the trade at $20.50. The stock changed hands in a range of $20.00 to $20.50, bringing its market capitalization to about $120.91 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $3.00 and was moved to the maximum level of $21.00. SecureAlert, Inc. (SecureAlert) markets and deploys offender management programs, combining global positioning system (GPS) tracking technologies, fulltime intervention-based monitoring capabilities and case management services.
For How Long SCRA Gloss will Attract Investors? Find out via this report
Exide Technologies (OTCMKTS:XIDEQ) added 9.92%, to complete the trading session at $0.194, with a total volume of 782,714 shares. The stock, on average, trades on a volume of 1.21 million shares. It floated in a range of $0.17 to $0.20 during the last trading session, with a beta value of 2.55. Its market capitalization now moved to about $15.44 million. In the past 52 weeks, the share price has not declined below $0.11 and above $3.75. Exide Technologies manufactures and supplies lead-acid batteries for transportation and industrial applications worldwide. The company operates in four segments: Transportation Americas, Transportation Europe and Rest of World (ROW), Industrial Energy Americas, and Industrial Energy Europe and ROW.
Will XIDEQ Continue To Move Higher? Find Out Here
Implant Sciences Corporation (OTCMKTS:IMSC) recorded a fall of -0.88% and was in a range of $1.12-$1.14 before closing at $1.13. The stock completed the day with a total volume of 132,202 shares, versus an average volume of 144,885 shares. The share price hit its 52-week low of $0.75 and $1.75 was the best price. Implant Sciences Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of sensors and systems for use in security, safety, and defense industries primarily in the United States, China, and Iraq.
Why Should Investors Buy IMSC After the Recent Fall? Just Go Here and Find Out
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) added 2% yesterday, bringing its market capitalization around $46.22 million. The share price, after opening at $0.57, made a high of $0.58 and hovered above $0.54 to end the day at $0.565. The total number of shares that changed hands during the session was 264,226. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. It is involved in developing Probuphine, an investigational subdermal implant for the treatment of opioid dependence.
Why Should Investors Buy TTNP After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)